跳至: [中文]   [數字0-9]   [ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ] 請輸入前幾個字:

顯示項目9076-9100 / 12927. (共518頁) << < 359 360 361 362 363 364 365 366 367 368 > >> 每頁顯示[10|25|50]項目

日期	題名	關聯
2003-12	Phase II study of gemcitabine and vinorelbine combination chemotherapy in patients with non-small-cell lung cancer not responding to previous chemotherapy	American Journal of Clinical Oncology. 2003 Dec;26(6):567-570.
2006-01	Phase II study of gemcitabine plus vinorelbine in the treatment of cisplatin-resistant nasopharyngeal carcinoma	Head and Neck. 2006 Jan;28(1):74-80.
2009-05-20	A phase II study of gemcitabine-based chemoradiotherapy (CCRT) after triplet induction chemotherapy (ICT) for locally advanced pancreatic cancer (LAPC): A Taiwan Cooperative Oncology Group (TCOG) study	Journal of Clinical Oncology. 2009 May 20;27(15):Abstract number e15562.
1997-04	Phase II study of ifosfamide and etoposide chemotherapy for extensive-disease small-cell lung cancer	Japanese Journal of Clinical Oncology. 1997 Apr;27(2):76-79.
2011-09	Phase II study of low-dose everolimus plus weekly cisplatin and 24-hour infusion of high-dose 5-fluorouracil and leucovorin for first-line treatment of metastatic or recurrent gastric cancers	European Journal of Cancer. 2011 Sep;47(Suppl 1):S467.
2011-09-23	A phase II study of neoadjuvant bio-chemotherapy with Cetuximab, Paclitaxel, and Cisplatin (CPC) followed by Cetuximab-based concurrent bio-radiotherapy in high-risk locally advanced head and neck cancer - representative of head and neck cancer study grou	European Journal of Cancer. 2011 Sep 23;47:S547-S548.
2000-08	Phase II study of tamoxifen, ifosfamide, epirubicin and cisplatin combination chemotherapy in patients with non-small cell lung cancer failing previous chemotherapy	Lung Cancer. 2000 Aug;29(2):139-146.
2010-10	A phase II study of weekly docetaxel and cisplatin plus oral tegafur/uracil and leucovorin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer	British Journal of Cancer. 2010 Oct;103(9):1343-1348.
2011-02	Phase II study of weekly low-dose everolimus plus weekly 24-hour infusions of cisplatin and high-dose 5-fluorouracil and leucovorin for first-line treatment in patients with advanced gastric cancers	Journal of Clinical Oncology. 2011 Feb;29(4):Abstract Number 86.
2004-08-02	Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer	British Journal of Cancer. 2004 Aug;91(3):453-458.
2005	Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer	Oncology. 2005;69(1):88-95.
2005-03-28	Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer	British Journal of Cancer. 2005 Mar;92(6):1013-1018.
2000-12	Phase II study with gemcitabine, ifosfamide and cisplatin in advanced non-small cell lung cancer	Lung Cancer. 2000 Dec;30(3):199-202.
2003-04	Phase II study with vinorelbine and cisplatin in advanced non-small cell lung cancer after failure of previous chemotherapy	Journal of the Chinese Medical Association. 2003 Apr;66(4):241-246.
2009-12	A phase II trial of biweekly oxaliplatin with simplified schedule of 48-h infusion of high-dose 5-fluorouracil and leucorvin for advanced biliary tract carcinoma	Cancer Chemotherapy and Pharmacology. 2009 Dec;65(1):151-157.
2006-06	A phase II trial of gemcitabine plus UFUR combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy	Lung Cancer. 2006 Jun;52(3):333-338.
1998-03	Phase II trial of intrapleural paclitaxel injection for non-small-cell lung cancer patients with malignant pleural effusions	Respiratory Medicine. 1998 Mar;92(3):473-479.
2022-07	A phase II trial of nivolumab, gemcitabine and S-1 as the frst-line treatment in patients with biliary tract cancer	Annals of Oncology. 2022 Jul;33(Suppl. 6):S478.
2007-09	A phase II trial of oxaliplatin with high-dose of 5-fluorouracil and leucovorin in the first-line treatment of inoperable, locally advanced or metastatic biliary tract cancer	EJC Supplements. 2007 Sep;5(4):268.
2000-02	A phase II trial of tamoxifen, ifosfamide, epirubicin, and cisplatin combination chemotherapy for inoperable non-small-cell lung cancer	American Journal of Clinical Oncology. 2000 Feb;23(1):13-17.
2005-06	A phase II trial of UFUR plus gemcitabine in non-small cell lung cancer patients failing previous platinum-based chemotherapy	Journal of Clinical Oncology. 2005 Jun;23(16):Abstract number 694S.
2000-02	A phase II trial of vinorelbine and cisplatin in previously untreated inoperable non-small-cell lung cancer	American Journal of Clinical Oncology. 2000 Feb;23(1):60-64.
2003-05	A phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (stage IIIb/IV) non-small-cell lung cancer patients aged 80 or older	Lung Cancer. 2003 May;40(2):221-226.
2016-05	Phase III randomized study of second line ADI-peg 20 (A) plus best supportive care versus placebo (P) plus best supportive care in patients (pts) with advanced hepatocellular carcinoma (HCC)	Journal of Clinical Oncology. 2016 May;34(15, Suppl. S):Abstract number 4017.
2018-06	Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma	Annals of Oncology. 2018 Jun;29(6):1402-1408.

顯示項目9076-9100 / 12927. (共518頁) << < 359 360 361 362 363 364 365 366 367 368 > >> 每頁顯示[10|25|50]項目